BioLineRx (BLRX) Receivables - Net: 2023-2025
Historic Receivables - Net for BioLineRx (BLRX) over the last 1 years, with Jun 2025 value amounting to $78,000.
- BioLineRx's Receivables - Net fell 97.55% to $78,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $78,000, marking a year-over-year decrease of 97.55%. This contributed to the annual value of $2.5 million for FY2024, which is 591.62% up from last year.
- According to the latest figures from Q2 2025, BioLineRx's Receivables - Net is $78,000, which was down 94.69% from $1.5 million recorded in Q1 2025.
- BioLineRx's 5-year Receivables - Net high stood at $3.6 million for Q3 2024, and its period low was $78,000 during Q2 2025.
- For the 3-year period, BioLineRx's Receivables - Net averaged around $2.0 million, with its median value being $2.5 million (2024).
- In the last 5 years, BioLineRx's Receivables - Net spiked by 591.62% in 2024 and then slumped by 97.55% in 2025.
- Quarterly analysis of 3 years shows BioLineRx's Receivables - Net stood at $358,000 in 2023, then spiked by 591.62% to $2.5 million in 2024, then slumped by 97.55% to $78,000 in 2025.
- Its Receivables - Net stands at $78,000 for Q2 2025, versus $1.5 million for Q1 2025 and $2.5 million for Q4 2024.